Skip to main content
CORESTEMCHEMON Inc. logo

CORESTEMCHEMON Inc. — Investor Relations & Filings

Ticker · 166480 ISIN · KR7166480004 KO Professional, scientific and technical activities
Open in API
Filings indexed 274 across all filing types
Latest filing 2022-01-04 Regulatory Filings
Country KR South Korea
Listing KO 166480

About CORESTEMCHEMON Inc.

https://www.corestemchemon.com/eng/main…

CORESTEMCHEMON Inc. is a biotechnology company operating through two main divisions: a biopharmaceutical unit and a non-clinical Contract Research Organization (CRO) unit. The biopharmaceutical division is dedicated to the research and development of new drugs based on stem cell therapy technology. Its clinical pipeline primarily targets neurodegenerative diseases, such as amyotrophic lateral sclerosis (ALS), cerebellar ataxia, and multiple sclerosis, as well as autoimmune diseases like systemic lupus erythematosus (SLE) and fibrosis. The non-clinical CRO division provides comprehensive preclinical services, conducting essential toxicity and efficacy evaluations for pharmaceuticals, biopharmaceuticals, cosmetics, and medical devices to support regulatory approval processes.

Recent filings

Filing Released Lang Actions
기타시장안내(연구개발 우수기업 매출액 특례적용 관련)
Regulatory Filings Classification · 1% confidence The document is a short announcement from the Korea Exchange (KRX) regarding a specific regulatory status (R&D excellence revenue exemption) for the company Corestem. It is a brief regulatory notice rather than a full financial report, and it does not fit into specific categories like M&A, dividends, or director dealings. Therefore, it falls under the general regulatory filing category.
2022-01-04 Korean
주주명부폐쇄기간또는기준일설정
Regulatory Filings Classification · 1% confidence The document is a short regulatory announcement regarding the setting of a record date and shareholder register closure for the purpose of holding an Annual General Meeting. It does not contain the full meeting materials or proxy statements, but rather serves as a formal notice of the upcoming meeting logistics. Given it is a regulatory announcement that does not fit into specific categories like dividend or share issuance, it is classified as a general regulatory filing.
2021-12-15 Korean
분기보고서 (2021.09)
Interim / Quarterly Report Classification · 1% confidence The document is a 'Quarterly Report' (분기보고서) for Corestem Inc. (코아스템(주)) covering the period from January 1, 2021, to September 30, 2021. It contains detailed financial data, business operations, and management analysis, which fits the definition of an Interim/Quarterly Report (IR). 9M 2021
2021-11-12 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 1% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details changes in share ownership by major shareholders and special related parties, including stock option exercises and market transactions. This falls under the 'Major Shareholding Notification' category.
2021-09-14 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 1% confidence The document is a Korean regulatory filing titled '임원ㆍ주요주주 특정증권등 소유상황보고서' (Report on Ownership of Specific Securities by Executives and Major Shareholders). This is a standard disclosure form required by the Financial Supervisory Service (FSS) in South Korea when an insider (executive or major shareholder) trades company stock. This falls under the category of 'Director's Dealing' (DIRS), which covers insider transactions by company directors and executives.
2021-09-14 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 1% confidence The document is a standard Korean regulatory filing titled '임원ㆍ주요주주 특정증권등 소유상황보고서' (Report on Ownership of Specific Securities by Executives and Major Shareholders). This is a mandatory disclosure required by the Financial Supervisory Service (FSS) and the Korea Exchange (KRX) when an insider (director or major shareholder) changes their shareholding position. This falls under the category of 'Director's Dealing' (DIRS) as it reports personal share transactions by company executives.
2021-09-14 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.